These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 406031)

  • 1. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom's macroglobulinaemia.
    Alexander P; Flanagan D; Rege K; Foss A; Hingorani M
    Eye (Lond); 2008 Aug; 22(8):1089-92. PubMed ID: 18600248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of small cell lung cancer with Waldenstrom's macroglobulinemia].
    Nakayama Y; Natsuaki M; Itoh T; Nishioka K
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Jun; 40(6):1021-4. PubMed ID: 1321869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.
    Ito K; Kawasaki T; Hirano K; Sekiguchi N
    Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperviscosity syndrome and Waldenström's macroglobulinemia].
    Shida M; Baba M; Sawada S
    Nihon Rinsho; 1992 Jan; 50 Suppl():298-303. PubMed ID: 1578695
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
    Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZ
    Semin Oncol; 2003 Apr; 30(2):226-30. PubMed ID: 12720141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3+ T lymphocytes and interleukin 2 in myelomatous blood hyperviscosity syndrome treated with plasmapheresis.
    Usnarska-Zubkiewicz L
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):317-22. PubMed ID: 9832072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 18. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia.
    Martino R; Shah A; Romero P; Brunet S; Sierra J; Domingo-Albós A; Fruchtman S; Isola L
    Bone Marrow Transplant; 1999 Apr; 23(7):747-9. PubMed ID: 10218857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in hyperviscosity syndrome.
    Avnstorp C; Nielsen H; Drachmann O; Hippe E
    Acta Med Scand; 1985; 217(1):133-7. PubMed ID: 3919530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.